SCHEMBL14601302

SCHEMBL14601302

CCOC(=O)[C@H](N)NC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CAD P27708 1/20 0.43
▸ ALOX15 P16050 1/20 0.42
▸ MGAM O43451 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SI P14410 1/20 0.42
▸ MGAM2 Q2M2H8 1/20 0.42
▸ SOAT1 P35610 1/20 0.42
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ METAP2 P50579 7/20 0.39
▸ METAP1 P53582 6/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8837118 1.00 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL28999753 0.84 CAD (0.55) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL10897143 0.79 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL1331748 0.79 LMNA (0.53) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL1330728 0.79 LMNA (0.53) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL1332017 0.79 LMNA (0.53) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL1332187 0.79 LMNA (0.53) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL81193 0.79 LMNA (0.53) ALDH1A1LMNAHSD17B10CADALOX15
SCHEMBL14523473 0.78 TSHR (0.41) ALDH1A1HSD17B10CADALOX15MGAM
SCHEMBL3787404 0.77 LMNA (0.51) ALDH1A1LMNAHSD17B10CADALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007034329-A2 COMPOUNDS AND METHODS FOR TREATMENT OF AMYLOID-BETA-PEPTIDE RELATED DISORDERS EXONHIT THERAPEUTICS SA (FR) 2007-03-29 — — WO disclosed
Send feedback